Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Abdelrahman Fouda

Concepts (205)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Retina
9
2026
76
3.430
Why?
Reperfusion Injury
8
2026
83
3.290
Why?
Retinal Diseases
6
2025
59
3.100
Why?
Arginase
10
2023
40
2.550
Why?
Histone Deacetylases
3
2026
59
1.910
Why?
Neuroprotective Agents
5
2021
101
1.850
Why?
Stroke
10
2022
520
1.700
Why?
Retinal Neovascularization
3
2025
7
1.530
Why?
Receptor, Angiotensin, Type 2
4
2022
23
1.470
Why?
Phagocytosis
3
2026
59
1.330
Why?
Macrophages
7
2026
380
1.310
Why?
Mice, Inbred C57BL
11
2026
1925
1.240
Why?
Mice, Knockout
9
2026
910
1.180
Why?
Angiotensin II Type 1 Receptor Blockers
4
2019
44
1.170
Why?
Renin-Angiotensin System
3
2019
58
1.160
Why?
Animals
32
2026
13528
1.080
Why?
Thiophenes
5
2022
45
0.980
Why?
Diabetic Retinopathy
3
2025
50
0.960
Why?
Brain
7
2021
1353
0.950
Why?
Sulfonamides
5
2022
139
0.920
Why?
Eye
1
2025
29
0.910
Why?
Ischemia
3
2024
158
0.900
Why?
Eye Diseases
1
2025
36
0.900
Why?
Infarction, Middle Cerebral Artery
6
2022
41
0.860
Why?
Aqueous Humor
1
2024
10
0.850
Why?
Retinal Artery Occlusion
1
2024
11
0.840
Why?
Drug Delivery Systems
2
2025
148
0.840
Why?
Nanoparticles
1
2025
133
0.830
Why?
Mice
14
2026
5982
0.780
Why?
Retinopathy of Prematurity
1
2022
16
0.730
Why?
Proteomics
1
2024
337
0.700
Why?
Endothelial Cells
7
2025
289
0.690
Why?
Minocycline
2
2017
15
0.640
Why?
Luminescent Agents
1
2020
1
0.630
Why?
Brain Injuries
1
2021
160
0.630
Why?
Muramidase
1
2020
15
0.620
Why?
Integrases
1
2020
44
0.620
Why?
Luminescent Proteins
1
2020
48
0.620
Why?
Retinal Vessels
1
2020
20
0.620
Why?
Cadherins
1
2020
62
0.610
Why?
Angiotensin-Converting Enzyme Inhibitors
2
2019
73
0.600
Why?
Endothelins
1
2019
16
0.590
Why?
Angiogenesis Inducing Agents
2
2016
8
0.580
Why?
Antigens, CD
1
2020
217
0.570
Why?
Inflammation
3
2021
653
0.560
Why?
Rats, Wistar
8
2022
192
0.560
Why?
Cerebrovascular Circulation
1
2019
132
0.540
Why?
Disease Models, Animal
12
2023
1517
0.530
Why?
Cognition Disorders
1
2019
199
0.530
Why?
Interleukin-10
1
2017
81
0.490
Why?
Brain-Derived Neurotrophic Factor
2
2016
30
0.490
Why?
Cerebral Hemorrhage
1
2017
102
0.480
Why?
Cognition
1
2019
346
0.480
Why?
Angiotensin II Type 2 Receptor Blockers
1
2016
7
0.470
Why?
Apoptosis
4
2026
1139
0.450
Why?
Endothelium, Vascular
5
2022
262
0.440
Why?
Microglia
4
2025
113
0.420
Why?
Diabetes Mellitus, Experimental
3
2022
138
0.410
Why?
Myeloid Cells
2
2024
45
0.400
Why?
Optic Nerve Injuries
2
2023
7
0.380
Why?
Brain Ischemia
4
2021
162
0.380
Why?
Neovascularization, Physiologic
3
2022
86
0.370
Why?
Tetrazoles
4
2018
41
0.360
Why?
Benzimidazoles
4
2018
50
0.360
Why?
Rats
7
2022
3164
0.360
Why?
Polyethylene Glycols
2
2022
95
0.350
Why?
Recovery of Function
6
2019
203
0.320
Why?
Male
15
2024
27444
0.320
Why?
Humans
17
2025
53246
0.320
Why?
Blood-Brain Barrier
2
2021
51
0.320
Why?
Oxygen
3
2025
338
0.300
Why?
Neovascularization, Pathologic
3
2022
158
0.290
Why?
Neurons
2
2021
394
0.270
Why?
Diabetes Mellitus
3
2016
321
0.250
Why?
Administration, Ophthalmic
1
2025
4
0.230
Why?
Ornithine
2
2023
17
0.230
Why?
Thromboembolism
2
2018
48
0.230
Why?
Nanotechnology
1
2025
31
0.230
Why?
Phosphopyruvate Hydratase
1
2024
10
0.210
Why?
Vitreous Body
1
2024
19
0.210
Why?
Paracentesis
1
2024
13
0.210
Why?
Eye Proteins
1
2024
17
0.210
Why?
Biphenyl Compounds
4
2018
31
0.210
Why?
Encephalomyelitis, Autoimmune, Experimental
2
2021
21
0.200
Why?
Ornithine Decarboxylase
1
2023
12
0.200
Why?
Vitrectomy
1
2024
61
0.200
Why?
Imidazoles
2
2022
114
0.200
Why?
Retinal Ganglion Cells
2
2020
15
0.190
Why?
Mass Spectrometry
1
2024
294
0.190
Why?
Motor Activity
3
2019
227
0.190
Why?
Signal Transduction
6
2022
1748
0.180
Why?
Mice, Transgenic
2
2021
561
0.180
Why?
Blood-Retinal Barrier
1
2021
6
0.180
Why?
Vascular Endothelial Growth Factor Receptor-2
1
2022
38
0.180
Why?
Tumor Necrosis Factor-alpha
1
2023
392
0.170
Why?
Copper
1
2022
47
0.170
Why?
Mitochondria
2
2025
447
0.170
Why?
Optic Neuritis
1
2021
21
0.170
Why?
Behavior, Animal
2
2019
187
0.160
Why?
Cytokines
1
2023
627
0.160
Why?
Recombinant Proteins
1
2021
489
0.160
Why?
Genes, Reporter
1
2020
87
0.150
Why?
Nitric Oxide
2
2018
233
0.150
Why?
Cell Survival
1
2021
600
0.150
Why?
Reactive Oxygen Species
1
2022
421
0.150
Why?
Recombination, Genetic
1
2020
95
0.150
Why?
Retinal Degeneration
1
2019
10
0.150
Why?
Receptors, Endothelin
1
2019
6
0.150
Why?
Receptors, Angiotensin
1
2019
11
0.150
Why?
Female
6
2024
28792
0.140
Why?
Animals, Newborn
1
2020
357
0.140
Why?
Nitric Oxide Synthase Type II
1
2018
64
0.140
Why?
Diagnostic Imaging
1
2020
176
0.140
Why?
Nitric Oxide Synthase
1
2018
64
0.140
Why?
Forecasting
1
2019
152
0.140
Why?
Multiple Sclerosis
1
2019
77
0.140
Why?
Gene Deletion
1
2019
279
0.140
Why?
Nitric Oxide Synthase Type III
1
2018
83
0.140
Why?
Cattle
3
2025
207
0.130
Why?
Vascular Stiffness
1
2017
24
0.130
Why?
Administration, Intravenous
1
2017
73
0.130
Why?
Tissue Plasminogen Activator
1
2018
108
0.130
Why?
Cells, Cultured
4
2025
1569
0.130
Why?
Fibrinolytic Agents
1
2018
132
0.130
Why?
Vascular Diseases
1
2017
75
0.120
Why?
Biomedical Research
1
2020
267
0.120
Why?
Acute Disease
1
2017
393
0.120
Why?
Injections, Intraventricular
1
2016
12
0.120
Why?
Angiotensins
1
2016
12
0.120
Why?
Receptor, Angiotensin, Type 1
1
2016
56
0.110
Why?
RNA, Small Interfering
1
2016
214
0.110
Why?
Alzheimer Disease
1
2019
338
0.110
Why?
Infant, Newborn
1
2022
2913
0.110
Why?
Molecular Targeted Therapy
1
2016
138
0.110
Why?
Neuronal Plasticity
1
2014
44
0.100
Why?
Thioredoxins
1
2014
26
0.100
Why?
Cerebral Cortex
1
2014
194
0.090
Why?
Carrier Proteins
1
2014
315
0.090
Why?
Optic Nerve
2
2023
46
0.090
Why?
Diabetes Mellitus, Type 2
1
2017
591
0.080
Why?
Hypertension
1
2016
554
0.080
Why?
Aged
1
2024
10430
0.080
Why?
Blood Pressure
3
2018
518
0.080
Why?
Cell Movement
2
2025
279
0.080
Why?
Treatment Outcome
2
2017
5597
0.080
Why?
Obesity
1
2017
1205
0.070
Why?
Middle Aged
1
2024
13422
0.070
Why?
Time Factors
3
2019
2992
0.060
Why?
Random Allocation
2
2018
284
0.060
Why?
Phenylenediamines
1
2025
7
0.060
Why?
Acrylamides
1
2025
12
0.060
Why?
Histone Deacetylase Inhibitors
1
2025
60
0.060
Why?
Glycolysis
1
2025
76
0.060
Why?
Vascular Endothelial Growth Factor A
2
2015
189
0.050
Why?
Nerve Crush
1
2023
2
0.050
Why?
Glutamates
1
2023
21
0.050
Why?
Glucose
1
2025
361
0.050
Why?
Cysteine
1
2022
50
0.040
Why?
Mitochondrial Dynamics
1
2021
22
0.040
Why?
Human Umbilical Vein Endothelial Cells
1
2022
102
0.040
Why?
Oxidative Stress
2
2017
820
0.040
Why?
HEK293 Cells
1
2022
235
0.040
Why?
Oxidation-Reduction
1
2022
333
0.040
Why?
Neuroglia
1
2019
39
0.040
Why?
Cell Line
1
2022
1016
0.040
Why?
Microvessels
1
2019
36
0.040
Why?
Sensory Gating
1
2018
1
0.040
Why?
PPAR gamma
1
2019
74
0.030
Why?
Rats, Inbred SHR
1
2018
42
0.030
Why?
Cell Hypoxia
1
2018
82
0.030
Why?
Locomotion
1
2018
79
0.030
Why?
Amyloid beta-Peptides
1
2018
65
0.030
Why?
Dietary Sucrose
1
2017
14
0.030
Why?
Up-Regulation
1
2019
456
0.030
Why?
Peptide Fragments
1
2018
209
0.030
Why?
Antihypertensive Agents
1
2018
130
0.030
Why?
Vasodilation
1
2017
100
0.030
Why?
Fibrosis
1
2017
198
0.030
Why?
Hippocampus
1
2018
195
0.030
Why?
Pilot Projects
1
2019
727
0.030
Why?
Double-Blind Method
1
2018
729
0.030
Why?
Sex Factors
1
2019
747
0.030
Why?
Arginine
1
2017
178
0.030
Why?
Enzyme Inhibitors
1
2017
371
0.030
Why?
Hydro-Lyases
1
2015
2
0.030
Why?
Brain Infarction
1
2015
13
0.030
Why?
Cerebrovascular Trauma
1
2015
11
0.030
Why?
Diet, High-Fat
1
2017
243
0.030
Why?
Diabetes Complications
1
2016
124
0.030
Why?
Matrix Metalloproteinases
1
2015
47
0.030
Why?
Insulin
1
2017
493
0.030
Why?
Blood Glucose
1
2017
491
0.030
Why?
Middle Cerebral Artery
1
2015
34
0.030
Why?
Psychomotor Performance
1
2015
126
0.030
Why?
Cell Communication
1
2015
73
0.030
Why?
Phenotype
1
2017
803
0.030
Why?
Genetic Predisposition to Disease
1
2017
533
0.030
Why?
Muscle Strength
1
2015
132
0.030
Why?
Comorbidity
1
2016
638
0.030
Why?
Stilbenes
1
2014
58
0.030
Why?
Epithelial Cells
1
2015
218
0.020
Why?
Pyridines
1
2015
135
0.020
Why?
Hypoglycemic Agents
1
2014
227
0.020
Why?
Clinical Trials as Topic
1
2014
466
0.020
Why?
Cell Proliferation
1
2015
1031
0.020
Why?
Fouda's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description